Home Site Map Make Your Home Page Suggestions Enquiry Advertise With Us
Sunday, October 12, 2008  
 
 
Press Releases
Features
Events
Special Articles
News Home
   
  News Updated on Sunday, October 12, 2008 6:14:19 AM
Top Stories
  India
  Asia
  World
  Sports
  Business
  Sci-Tec
  Health
  Entertainment
 
 Health

Artificial cells boost immunity to cancer
New York | February 27, 2008 11:55:01 AM IST
 

It may now be possible to artificially boost one's immune system, allowing the body to combat a host of diseases, including cancer, a new study says.

This can be done with the help of synthetic cells that prompt a 45-fold T-cell activation and expansion - something that will help fight cancer as well as several infectious diseases.

T-cells are white blood cells that play a key role in cell-mediated immunity.

These artificial cells, developed by Tarek Fahmy of Yale University and his research student Erin Steenblock, are synthesised out of a material used for biodegradable sutures.

The duo has reported their findings in the latest issue of the journal Molecular Theory.

The authors claim the new method is the first "off-the-shelf" antigen-presenting artificial cell that can be tuned to target a specific disease or infection.

"This procedure is likely to make it to the clinic rapidly," said Fahmy. "All of the materials we use are natural, biodegradable (and) already have FDA (the US Food and Drug Administration) approval."

Cancer, viral infections and autoimmune diseases have responded to the therapy that boosts a patient's own antigen-specific T-cells.

In previous procedures, the immune cells were harvested and then exposed to cells that stimulate activation and production of antigen-specific T-cells. The "boosted" immune cells were then transfused into the patient to attack the disease.

Their limitations include costly and tedious isolation of cells for individual patients and the risk of adverse reaction to foreign cells, according to Yale researchers.

They also pointed to difficulty in obtaining and maintaining sufficient numbers of activated T-cells for effective therapeutic response.

(IANS)

 More Stories

Indian tail wags after batsmen fail to counter Aussie attack 

India vs Australia 1st Test third day 

Haddin, Zaheer in slegding row 

Indian struggle to reach 210 for six at tea 

Johnson wrecks top order, India reduced to 133 for 4 at lunch 

S M Krishna appointed Honorary Life President of AITA 

Hard preparation was the secret behind my success: Johnson 

Now Indian bowlers should bring us back into the match: Dravid 


Print this Page
Printer Friendly Version
E-Mail this page to a Friend
Send This page to A Friend

Search Archives :  



Quick Links - Webindia123.com
Services
Hobbies
 
Entertainment
Classifieds
Career / Education
UK, USA, Canada
Utilities
E-Booking
India Reference
 
 
 
 
 
 
 
 
 
IndianStates
 
 
 
 
  
 
 
 
 
Pradesh

Copyright 2000-2008 Suni Systems (P) Ltd.
All rights reserved